Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Browse by Research Team

Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Source
Jump to: 2020 | 2019 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007

2020

Hypoxia and exercise interactions on skeletal muscle insulin sensitivity in obese subjects with metabolic syndrome: results of a randomized controlled trial.
Mai, K. and Klug, L. and Rakova, N. and Piper, S.K. and Mähler, A. and Bobbert, T. and Schulz-Menger, J. and Spranger, J. and Boschmann, M. and Luft, F.C.
International Journal of Obesity 44 (5): 1119-1128. May 2020

2019

Interactions between neural decision-making circuits predict long-term dietary treatment success in obesity.
Weygandt, M. and Spranger, J. and Leupelt, V. and Maurer, L. and Bobbert, T. and Mai, K. and Haynes, J.D.
NeuroImage 184 : 520-534. 1 January 2019

2017

Insulin-like growth factor (IGF) binding protein-2, independently of IGF-1, induces GLUT-4 translocation and glucose uptake in 3T3-L1 adipocytes.
Assefa, B. and Mahmoud, A.M. and Pfeiffer, A.F.H. and Birkenfeld, A.L. and Spranger, J. and Arafat, A.M.
Oxidative Medicine and Cellular Longevity 2017 : 3035184. 20 December 2017

Glucagon decreases IGF-1 bioactivity in humans, independently of insulin, by modulating its binding proteins.
Sarem, Z. and Bumke-Vogt, C. and Mahmoud, A.M. and Assefa, B. and Weickert, M.O. and Adamidou, A. and Baehr, V. and Frystyk, J. and Moehlig, M. and Spranger, J. and Lieske, S. and Birkenfeld, A.L. and Pfeiffer, A.F.H. and Arafat, A.M.
Journal of Clinical Endocrinology and Metabolism 102 (9): 3480-3490. 1 September 2017

Renal function is independently associated with circulating betatrophin.
Maurer, L. and Schwarz, F. and Fischer-Rosinsky, A. and Schlueter, N. and Brachs, S. and Moehlig, M. and Pfeiffer, A. and Mai, K. and Spranger, J. and Bobbert, T.
PLoS ONE 12 (3): e0173197. 3 March 2017

Caloric restriction in older adults - differential effects of weight loss and reduced weight on brain structure and function.
Prehn, K. and Jumpertz von Schwartzenberg, R. and Mai, K. and Zeitz, U. and Witte, A.V. and Hampel, D. and Szela, A.M. and Fabian, S. and Grittner, U. and Spranger, J. and Floeel, A.
Cerebral Cortex 27 (3): 1765-1778. 1 March 2017

2016

Weight loss partially restores glucose-driven betatrophin response in humans.
Maurer, L. and Brachs, S. and Decker, A.M. and Brachs, M. and Leupelt, V. and Jumpertz von Schwartzenberg, R. and Ernert, A. and Bobbert, T. and Krude, H. and Spranger, J. and Mai, K.
Journal of Clinical Endocrinology and Metabolism 101 (11): 4014-4020. November 2016

Interindividual variation in DNA methylation at a putative POMC metastable epiallele is associated with obesity.
Kuehnen, P. and Handke, D. and Waterland, R.A. and Hennig, B.J. and Silver, M. and Fulford, A.J. and Dominguez-Salas, P. and Moore, S.E. and Prentice, A.M. and Spranger, J. and Hinney, A. and Hebebrand, J. and Heppner, F.L. and Walzer, L. and Groetzinger, C. and Gromoll, J. and Wiegand, S. and Grueters, A. and Krude, H.
Cell Metabolism 24 (3): 502-509. 13 September 2016

ANP system activity predicts variability of fat mass reduction and insulin sensitivity during weight loss.
Brachs, M. and Wiegand, S. and Leupelt, V. and Ernert, A. and Kintscher, U. and Jumpertz von Schwarzenberg, R. and Decker, A.M. and Bobbert, T. and Hübner, N. and Chen, W. and Krude, H. and Spranger, J. and Mai, K.
Metabolism 65 (6): 935-943. June 2016

2015

Palliative treatment of uncontrollable hypercalcemia due to parathyrotoxicosis: denosumab as rescue therapy.
Jumpertz von Schwartzenberg, R. and Elbelt, U. and Ventz, M. and Mai, K. and Kienitz, T. and Maurer, L and Rose, T. and Rueckert, J.C. and Strasburger, C.J. and Spranger, J.
Endocrinology Diabetes and Metabolism Case Reports 2015 : 150082. 29 October 2015

Circulating insulin-like growth factor binding protein-3 predicts one-year outcome after ischemic stroke.
Ebinger, M. and Ipsen, N. and Leonards, C.O. and Empl, L. and Hanne, L. and Liman, T. and Mai, K. and Strasburger, C.J. and Spranger, J. and Endres, M.
Experimental and Clinical Endocrinology & Diabetes 123 (8): 461-465. September 2015

High prevalence of anaemia among African migrants in Germany persists after exclusion of iron deficiency and erythrocyte polymorphisms.
Mueller, S.A. and Amoah, S.K.B. and Meese, S. and Spranger, J. and Mockenhaupt, F.P.
Tropical Medicine & International Health 20 (9): 1180-1189. September 2015

Knockdown of Indy/CeNac2 extends Caenorhabditis elegans life span by inducing AMPK/aak-2.
Schwarz, F. and Karadeniz, Z. and Fischer-Rosinsky, A. and Willmes, D.M. and Spranger, J. and Birkenfeld, A.L.
Aging 7 (8): 553-567. August 2015

Chemerin and prediction of diabetes mellitus type 2.
Bobbert, T. and Schwarz, F. and Fischer-Rosinsky, A. and Maurer, L. and Moehlig, M. and Pfeiffer, A.F.H. and Mai, K. and Spranger, J.
Clinical Endocrinology 82 (6): 838-843. June 2015

Impulse control in the dorsolateral prefrontal cortex counteracts post-diet weight regain in obesity.
Weygandt, M. and Mai, K. and Dommes, E. and Ritter, K. and Leupelt, V. and Spranger, J. and Haynes, J.D.
NeuroImage 109 : 318-327. 1 April 2015

Untargeted metabolic profiling identifies altered serum metabolites of type 2 diabetes mellitus in a prospective, nested case control study.
Drogan, D. and Dunn, W.B. and Lin, W. and Buijsse, B. and Schulze, M.B. and Langenberg, C. and Brown, M. and Floegel, A. and Dietrich, S. and Rolandsson, O. and Wedge, D.C. and Goodacre, R. and Forouhi, N.G. and Sharp, S.J. and Spranger, J. and Wareham, N.J. and Boeing, H.
Clinical Chemistry 61 (3): 487-497. March 2015

Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma.
Elbelt, U. and Trovato, A. and Kloth, M. and Gentz, E. and Finke, R. and Spranger, J. and Galas, D. and Weber, S. and Wolf, C. and Koenig, K. and Arlt, W. and Buettner, R. and May, P. and Allolio, B. and Schneider, J.G.
Journal of Clinical Endocrinology and Metabolism 100 (1): E119-E128. January 2015

2014

Metabolic actions of natriuretic peptides and therapeutic potential in the metabolic syndrome.
Schlueter, N. and de Sterke, A. and Willmes, D.M. and Spranger, J. and Jordan, J. and Birkenfeld, A.L.
Pharmacology & Therapeutics 144 (1): 12-27. October 2014

Skepticism is unjustified.
Abholz, H.H. and Egidi, G. and Mueller, U.A. and Spranger, J.
Deutsches Aerzteblatt International 111 (25): 433. 20 June 2014

Reference intervals for insulin-like growth factor-1 (IGF-1) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-1 immunoassay conforming to recent international recommendations.
Bidlingmaier, M. and Friedrich, N. and Emeny, R.T. and Spranger, J. and Wolthers, O.D. and Roswall, J. and Koerner, A. and Obermayer-Pietsch, B. and Huebener, C. and Dahlgren, J. and Frystyk, J. and Pfeiffer, A.F.H. and Doering, A. and Bielohuby, M. and Wallaschofski, H. and Arafat, A.M.
Journal of Clinical Endocrinology and Metabolism 99 (5): 1712-1721. May 2014

Inflammation-induced acute phase response in skeletal muscle and critical illness myopathy.
Langhans, C. and Weber-Carstens, S. and Schmidt, F. and Hamati, J. and Kny, M. and Zhu, X. and Wollersheim, T. and Koch, S. and Krebs, M. and Schulz, H. and Lodka, D. and Saar, K. and Labeit, S. and Spies, C. and Hubner, N. and Spranger, J. and Spuler, S. and Boschmann, M. and Dittmar, G. and Butler-Browne, G. and Mouly, V. and Fielitz, J.
PLoS ONE 9 (3): e92048. 20 March 2014

Dynamics of myosin degradation in intensive care unit-acquired weakness during severe critical illness.
Wollersheim, T. and Woehlecke, J. and Krebs, M. and Hamati, J. and Lodka, D. and Luther-Schroeder, A. and Langhans, C. and Haas, K. and Radtke, T. and Kleber, C. and Spies, C. and Labeit, S. and Schuelke, M. and Spuler, S. and Spranger, J. and Weber-Carstens, S. and Fielitz, J.
Intensive Care Medicine 40 (4): 528-538. 15 February 2014

2013

The impact of insulin-independent, glucagon-induced suppression of total ghrelin on satiety in obesity and type 1 diabetes mellitus.
Arafat, A.M. and Weickert, M.O. and Adamidou, A. and Otto, B. and Perschel, F.H. and Spranger, J. and Moehlig, M. and Pfeiffer, A.F.H.
Journal of Clinical Endocrinology and Metabolism 98 (10): 4133-4142. October 2013

Arginine vasopressin-dependent and AVP-independent mechanisms of renal fluid absorption during thirsting despite glucocorticoid-mediated vasopressin suppression.
Ufer, F. and Diederich, S. and Pedersen, E.B. and Spranger, J. and Pfeiffer, A.F.H. and Baehr, V. and Mai, K.
Clinical Endocrinology 78 (3): 431-437. March 2013

Critical illness myopathy and GLUT4 - significance of insulin and muscle contraction.
Weber-Carstens, S. and Schneider, J. and Wollersheim, T. and Assmann, A. and Bierbrauer, J. and Marg, A. and Al Hasani, H. and Chadt, A. and Wenzel, K. and Koch, S. and Fielitz, J. and Kleber, C. and Faust, K. and Mai, K. and Spies, C.D. and Luft, F.C. and Boschmann, M. and Spranger, J. and Spuler, S.
American Journal of Respiratory and Critical Care Medicine 187 (4): 387-396. 15 February 2013

2012

Sexual dimorphic regulation of body weight dynamics and adipose tissue lipolysis.
Benz, V. and Bloch, M. and Wardat, S. and Boehm, C. and Maurer, L. and Mahmoodzadeh, S. and Wiedmer, P. and Spranger, J. and Foryst-Ludwig, A. and Kintscher, U.
PLoS ONE 7 (5): e37794. 25 May 2012

A distinct metabolic signature predicts development of fasting plasma glucose.
Hische, M. and Larhlimi, A. and Schwarz, F. and Fischer-Rosinsky, A. and Bobbert, T. and Assmann, A. and Catchpole, G.S. and Pfeiffer, A.F.H. and Willmitzer, L. and Selbig, J. and Spranger, J.
Journal of Clinical Bioinformatics 2 : 3. 2 February 2012

Early type II fiber atrophy in intensive care unit patients with nonexcitable muscle membrane.
Bierbrauer, J. and Koch, S. and Olbricht, C. and Hamati, J. and Lodka, D. and Schneider, J. and Luther-Schroeder, A. and Kleber, C. and Faust, K. and Wiesener, S. and Spies, C.D. and Spranger, J. and Spuler, S. and Fielitz, J. and Weber-Carstens, S.
Critical Care Medicine 40 (2): 647-650. February 2012

2011

Skeletal muscle 11beta-HSD1 controls glucocorticoid-induced proteolysis and expression of E3 ubiquitin ligases atrogin-1 and MuRF-1.
Biedasek, K. and Andres, J. and Mai, K. and Adams, S. and Spuler, S. and Fielitz, J. and Spranger, J.
PLoS ONE 6 (1): e16674. 31 January 2011

2010

Plasma γ-glutamyltransferase, cysteinyl-glycine, and oxidized low-density lipoprotein: a pathway associated with myocardial infarction risk?
Drogan, D. and Weikert, C. and Dierkes, J. and Klipstein-Grobusch, K. and Buijsse, B. and Moehlig, M. and Pfeiffer, A.F. and Pischon, T. and Spranger, J. and Boeing, H.
Arteriosclerosis Thrombosis and Vascular Biology 30 (10): 2053-2058. October 2010

Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study.
Weber-Carstens, S. and Deja, M. and Koch, S. and Spranger, J. and Bubser, F. and Wernecke, K.D. and Spies, C.D. and Spuler, S. and Keh, D.
Critical Care 14 (3): R119. 18 June 2010

2009

Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth factor-21.
Mai, K. and Andres, J. and Biedasek, K. and Weicht, J. and Bobbert, T. and Sabath, M. and Meinus, S. and Reinecke, F. and Moehlig, M. and Weickert, M.O. and Clemenz, M. and Pfeiffer, A.F. and Kintscher, U. and Spuler, S. and Spranger, J.
Diabetes 58 (7): 1532-1538. July 2009

2008

Influences of levodopa on adipose tissue and skeletal muscle metabolism in patients with idiopathic Parkinson's disease.
Adams, F. and Boschmann, M. and Lobsien, E. and Kupsch, A. and Lipp, A. and Franke, G. and Leisse, M.C. and Janke, J. and Gottschalk, S. and Spranger, J. and Jordan, J.
European Journal of Clinical Pharmacology 64 (9): 863-870. September 2008

Plasma resistin levels and risk of myocardial infarction and ischemic stroke.
Weikert, C. and Westphal, S. and Berger, K. and Dierkes, J. and Moehlig, M. and Spranger, J. and Rimm, E.B. and Willich, S.N. and Boeing, H. and Pischon, T.
The Journal of clinical endocrinology and metabolism 93 (7): 2647-2653. July 2008

2007

Comparison of relative and attributable risk of myocardial infarction and stroke according to C-reactive protein and low-density lipoprotein cholesterol levels.
Pischon, T. and Moehlig, M. and Hoffmann, K. and Spranger, J. and Weikert, C. and Willich, S.N. and Pfeiffer, A.F. and Boeing, H.
European Journal of Epidemiology 22 (7): 429-438. July 2007

This list was generated on Fri Mar 29 02:21:14 2024 CET.
Open Access
MDC Library